Sodium Iodide Symporter (NIS) in the Management of Patients with Thyroid Carcinoma
-
-
저자
정준기
김현우
윤해원
천기정
-
제어번호
105927340
-
학술지명
핵의학 분자영상
-
권호사항
Vol.
52
No.
5
[
2018
]
-
발행처
대한핵의학회
-
발행처 URL
http://www.ksnm.or.kr
-
자료유형
학술저널
-
수록면
325-326
-
언어
English
-
출판년도
2018
-
등재정보
KCI등재
-
판매처
'
Sodium Iodide Symporter (NIS) in the Management of Patients with Thyroid Carcinoma' 의 참고문헌
-
Wildtype p53 enhances the cytotoxic effect of radionuclide gene therapy using sodium iodide symporter in a murine anaplastic thyroid cancer model
-
The benefits and risks of I-131 therapy in patients with well-differentiated thyroid cancer
-
Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma
-
-
Overview of the management of differentiated thyroid cancer
-
Lesionalized Therapy beyond Personalized Therapy in Cancer Management
-
Expression of sodium-iodide symporter and TSH receptor in subclinical metastatic lymph nodes of papillary thyroid microcarcinoma
-
-
Effectiveness of retinoic acid treatment for redifferentiation of thyroid cancer in relation to recovery of radioiodine uptake
-
-
Death but one unintended consequence of gene-therapy trial
-
Codonoptimized human sodium iodide symporter (opt-hNIS) as a sensitive reporter and efficient therapeutic gene
-
Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis
'
Sodium Iodide Symporter (NIS) in the Management of Patients with Thyroid Carcinoma'
의 유사주제(
) 논문
